{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:00:43Z","timestamp":1778169643308,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1245\/s10434-014-3660-3","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T21:32:25Z","timestamp":1395955945000},"page":"2127-2128","source":"Crossref","is-referenced-by-count":1,"title":["Regional Delivery of Oncolytic Vaccinia Virus: It\u2019s Time for Clinical Trials"],"prefix":"10.1245","volume":"21","author":[{"given":"Stephanie","family":"Downs-Canner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"3660_CR1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magee","year":"2014","unstructured":"Magee D, Zenati MS, Austin F, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159\u201365.","journal-title":"Ann Surg Oncol."},{"key":"3660_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","volume":"19","author":"J Heo","year":"2013","unstructured":"Heo J, Reid T, Ruo L, et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med. 2013;19:329\u201336.","journal-title":"Nat Med."},{"key":"3660_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01243894-200609000-00017","volume":"1","author":"ZB Zhu","year":"2006","unstructured":"Zhu ZB, Makhija SK, Lu B, et al. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses. J Thorac Oncol. 2006;1:701\u201311.","journal-title":"J Thorac Oncol."},{"key":"3660_CR4","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-07-6265","volume":"68","author":"A Gauvrit","year":"2008","unstructured":"Gauvrit A, Brandler S, Sapede-Peroz C, et al. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response. Cancer Res. 2008;68:4882\u201392.","journal-title":"Cancer Res."},{"key":"3660_CR5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.surg.2013.06.004","volume":"154","author":"LJ Belin","year":"2013","unstructured":"Belin LJ, Ady JW, Lewis C, et al. An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT\/CT imaging in an orthotopic model of malignant pleural mesothelioma. Surgery. 2013;154:486\u201395.","journal-title":"Surgery."},{"key":"3660_CR6","first-page":"8751","volume":"61","author":"JA McCart","year":"2001","unstructured":"McCart JA, Ward JM, Lee J, et al. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res. 2001;61:8751\u20137.","journal-title":"Cancer Res."},{"key":"3660_CR7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.20.6.1562","volume":"20","author":"PA Vasey","year":"2002","unstructured":"Vasey PA, Shulman LN, Campos S, et al. Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene\u2013Deleted Adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3\u00a0weeks in patients with recurrent\/refractory epithelial ovarian cancer. J Clin Oncol. 2002;20:1562\u20139.","journal-title":"J Clin Oncol."},{"key":"3660_CR8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","volume":"70","author":"E Galanis","year":"2010","unstructured":"Galanis E, Hartmann LC, Cliby WA, et al. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010;70:875\u201382.","journal-title":"Cancer Res."},{"key":"3660_CR9","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-10-0791","volume":"16","author":"KJ Kimball","year":"2010","unstructured":"Kimball KJ, Preuss MA, Barnes MN, et al. A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res. 2010;16:5277\u201387.","journal-title":"Clin Cancer Res."},{"key":"3660_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2013.06.003","volume":"130","author":"KH Kim","year":"2013","unstructured":"Kim KH, Dmitriev IP, Saddekni S, et al. A phase I clinical trial of Ad5\/3-\u039424, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer. Gynecol Oncol. 2013;130:518\u201324.","journal-title":"Gynecol Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3660-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3660-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:24:23Z","timestamp":1559647463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3660-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3660"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3660-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}